Literature DB >> 31638308

Correlation between frailty and disease activity in patients with rheumatoid arthritis: Data from the CHIKARA study.

Masahiro Tada1, Yutaro Yamada2, Koji Mandai2, Noriaki Hidaka1.   

Abstract

AIM: Frailty is defined as the degradation of physical and cognitive function in older adults. The relationship between frailty and disease activity in patients with rheumatoid arthritis is unclear. Factors related to frailty in Japanese rheumatoid arthritis patients were investigated in a cross-sectional analysis.
METHODS: Of 100 patients who entered the prospective, observational Correlation research of sarcopenia, skeletal muscle and disease activity in rheumatoid arthritis (CHIKARA) study, 95 completed a frailty check list (maximal score 25), and were classified as frail (8-25 points), pre-frail (4-7 points) and normal (0-3 points). The relationship with disease activity was investigated in the frailty, pre-frailty and normal groups. Relationships between clinical variables and frailty were evaluated by univariate and multiple logistic regression analyses.
RESULTS: The prevalences of frailty, pre-frailty and normal were 18.9%, 38.9% and 42.2%, respectively. The disease activity score 28 erythrocyte sedimentation rate, matrix metalloproteinase 3 and modified health assessment questionnaire were higher in the frailty group. In remission, 66.6% were normal and 6.7% had frailty, but with moderate and high disease activity, 13.3% were normal and 46.7% had frailty. On univariate analysis, factors positively related to frailty were age, locomotive syndrome, disease activity score 28 erythrocyte sedimentation rate, matrix metalloproteinase 3, use of biological disease-modifying antirheumatic drugs or targeted synthetic disease-modifying antirheumatic drugs, Steinbrocker class and modified health assessment questionnaire; and the leg muscle score and grip strength were negatively related. Matrix metalloproteinase 3 was the only independent factor on multivariate logistic analysis. In patients aged >60 years, this tendency was similar.
CONCLUSIONS: Frailty was found to be related to disease activity and physical function in rheumatoid arthritis. Control of disease activity appears important to prevent frailty. Geriatr Gerontol Int 2019; 19: 1220-1225.
© 2019 Japan Geriatrics Society.

Entities:  

Keywords:  bioelectrical impedance analysis; disease activity; frailty; prospective observational study; rheumatoid arthritis

Mesh:

Year:  2019        PMID: 31638308     DOI: 10.1111/ggi.13795

Source DB:  PubMed          Journal:  Geriatr Gerontol Int        ISSN: 1447-0594            Impact factor:   2.730


  8 in total

1.  Daily physical activity measured by a wearable activity monitoring device in patients with rheumatoid arthritis.

Authors:  Masahiro Tada; Yutaro Yamada; Koji Mandai; Yoshinari Matsumoto; Noriaki Hidaka
Journal:  Clin Rheumatol       Date:  2022-03-31       Impact factor: 3.650

2.  Factors associated with frailty in Japanese patients with rheumatoid arthritis: results from the Institute of Rheumatology Rheumatoid Arthritis cohort study.

Authors:  Takefumi Furuya; Koei Oh; Katsunori Ikari; Eisuke Inoue; Eiichi Tanaka; Hisashi Yamanaka; Masayoshi Harigai
Journal:  Clin Rheumatol       Date:  2021-09-29       Impact factor: 2.980

3.  Association between Malnutrition and Quality of Life in Elderly Patients with Rheumatoid Arthritis.

Authors:  Wojciech Tański; Justyna Wójciga; Beata Jankowska-Polańska
Journal:  Nutrients       Date:  2021-04-12       Impact factor: 5.717

4.  Frailty in rheumatoidrmdopen-2021-002111 arthritis and its relationship with disease activity, hospitalisation and mortality: a longitudinal analysis of the Scottish Early Rheumatoid Arthritis cohort and UK Biobank.

Authors:  Peter Hanlon; Fraser Morton; Stefan Siebert; Bhautesh D Jani; Barbara I Nicholl; Jim Lewsey; David McAllister; Frances S Mair
Journal:  RMD Open       Date:  2022-03

5.  Inflammatory Bowel Disease Patients Who Respond to Treatment with Anti-tumor Necrosis Factor Agents Demonstrate Improvement in Pre-treatment Frailty.

Authors:  Bharati D Kochar; Winston Cai; Ashwin N Ananthakrishnan
Journal:  Dig Dis Sci       Date:  2021-05-01       Impact factor: 3.199

6.  Screening for sarcopenia and obesity by measuring thigh muscle and fat thickness by ultrasound in patients with rheumatoid arthritis.

Authors:  Masahiro Tada; Yutaro Yamada; Koji Mandai; Noriaki Hidaka
Journal:  Osteoporos Sarcopenia       Date:  2021-06-16

Review 7.  Frailty in Rheumatic Diseases.

Authors:  Francesca Motta; Antonio Sica; Carlo Selmi
Journal:  Front Immunol       Date:  2020-10-29       Impact factor: 7.561

Review 8.  Sarcopenia, immune-mediated rheumatic diseases, and nutritional interventions.

Authors:  Alfonso J Cruz-Jentoft; Susana Romero-Yuste; Eugenio Chamizo Carmona; Joan M Nolla
Journal:  Aging Clin Exp Res       Date:  2021-02-10       Impact factor: 3.636

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.